{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T06:44:48Z","timestamp":1774507488361,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biotechnology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jbiotec.2016.01.015","type":"journal-article","created":{"date-parts":[[2016,1,18]],"date-time":"2016-01-18T16:47:51Z","timestamp":1453135671000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["A peptide-linked recombinant glucocerebrosidase for targeted neuronal delivery: Design, production, and assessment"],"prefix":"10.1016","volume":"221","author":[{"given":"Paul A.","family":"Gramlich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Westbroek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo A.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola","family":"Awad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Mello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary P.","family":"Remington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wujuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Sidransky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Betenbaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul S.","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbiotec.2016.01.015_bib0005","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/protein\/14.8.529","article-title":"Design of the linkers which effectively separate domains of a bifunctional fusion protein","volume":"14","author":"Arai","year":"2001","journal-title":"Protein Eng."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0010","doi-asserted-by":"crossref","first-page":"14861","DOI":"10.1016\/S0021-9258(18)82412-7","article-title":"Human acid beta-glucosidase: N-glycosylation site occupancy and the effect of glycosylation on enzymatic activity","volume":"268","author":"Berg-Fussman","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1432-1033.1986.tb09978.x","article-title":"1H NMR study of motility and conformational constraints within the proline-rich N-terminal of the LC1 alkali light chain of skeletal myosin","volume":"160","author":"Bhandari","year":"1986","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0020","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1523\/JNEUROSCI.4785-13.2014","article-title":"Comparison of five peptide delivery vectors for improved brain delivery of the lysosomal enzyme arylsulfatase A","volume":"34","author":"B\u00f6ckenhoff","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0025","article-title":"Generation of Chinese Hamster Ovary cell line producing recombinant human glucocerebrosidase","author":"Branco Novo","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0030","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.expneurol.2010.07.023","article-title":"Intracerebroventricular delivery of glucocerebrosidase reduces substrates and increases lifespan in a mouse model of neuronopathic Gaucher disease","volume":"225","author":"Cabrera-Salazar","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043310","article-title":"Systemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher disease","author":"Cabrera-Salazar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0040","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.3390\/ijms13066883","article-title":"Fragment C of tetanus toxin: new insights into its neuronal signaling pathway","volume":"13","author":"Calvo","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0045","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jconrel.2006.10.031","article-title":"The taming of the cell penetrating domain of the HIV Tat: myths and realities","volume":"17","author":"Chauhan","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0050","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","article-title":"Fusion protein linkers: property, design, and functionality","volume":"65","author":"Chen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0055","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11948-010-9201-y","article-title":"Avoiding twisted pixels: ethical guidelines for the appropriate use and manipulation of scientific digital images","volume":"16","author":"Cromey","year":"2010","journal-title":"Sci. Eng. Ethics"},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0060","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s00018-005-5109-0","article-title":"Cell-penetrating peptides: tools for intracellular delivery of therapeutics","volume":"62","author":"Deshayes","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0065","doi-asserted-by":"crossref","DOI":"10.1002\/9780470151808.sc02d02s6","article-title":"Isolating, expanding, and infecting human and rodent fetal neural progenitor cells","author":"Ebert","year":"2008","journal-title":"Curr. Protoc. Stem Cell Biol."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0070","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0950-3536(97)80035-2","article-title":"Neuronopathic forms of Gaucher's disease","volume":"10","author":"Erickson","year":"1997","journal-title":"Baillieres Clin. Haematol."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0014-5793(86)81020-1","article-title":"Sequence-imposed structural constraints in the TonB protein of E coli","volume":"208","author":"Evans","year":"1986","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0080","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2147\/TCRM.S6865","article-title":"Review of miglustat for clinical management in Gaucher disease type 1","volume":"4","author":"Ficicioglu","year":"2008","journal-title":"Ther. Clin. Risk Manage."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0085","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1046\/j.1471-4159.2000.0742528.x","article-title":"Enhancement of diphtheria toxin potency by replacement of the receptor binding domain with tetanus toxin C-fragment: a potential vector for delivering heterologous proteins to neurons","volume":"74","author":"Francis","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.brainres.2004.03.007","article-title":"Tetanus toxin fragment C as a vector to enhance delivery of proteins to the CNS","volume":"1011","author":"Francis","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0095","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","article-title":"Cellular uptake of the tat protein from human immunodeficiency virus","volume":"55","author":"Frankel","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0100","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1227\/01.NEU.0000255444.44365.B9","article-title":"A means for targeting therapeutics to peripheral nervous system neurons with axonal damage","volume":"60","author":"Federici","year":"2007","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0105","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1007\/s11095-012-0667-y","article-title":"Targeted delivery of proteins into the central nervous system mediated by rabies virus glycoprotein-derived peptide","volume":"29","author":"Fu","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0110","article-title":"A novel peptide delivers plasmids across blood\u2013brain barrier into neuronal cells as a single-component transfer vector","author":"Fu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0115","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s11095-013-1068-6","article-title":"Cellular uptake mechanism and therapeutic utility of a novel peptide in targeted-delivery of proteins into neuronal cells","volume":"30","author":"Fu","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0120","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/bm401906p","article-title":"RVG-peptide-linked trimethylated chitosan for delivery of siRNA to the brain","volume":"15","author":"Gao","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0125","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/protein\/15.11.871","article-title":"An analysis of protein domain linkers: their classification and role in protein folding","volume":"15","author":"George","year":"2003","journal-title":"Protein Eng."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0130","doi-asserted-by":"crossref","first-page":"8339","DOI":"10.1002\/anie.201202001","article-title":"Peptide-mediated blood\u2013brain barrier transport of polymersomes","volume":"51","author":"Georgieva","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0135","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1021\/bc900445g","article-title":"Cellular trafficking and photochemical internalization of cell penetrating peptide linked cargo proteins: a dual fluorescent labeling study","volume":"22","author":"Gillmeister","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0140","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/j.biomaterials.2011.12.017","article-title":"Target delivery of a gene into the brain using the RVG29-oligoarginine peptide","volume":"33","author":"Gong","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0145","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/S0021-9258(17)42166-1","article-title":"Analysis of human acid \u03b2-glucosidase by site-directed mutagenesis and heterologous expression","volume":"269","author":"Grace","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0150","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3109\/1061186X.2013.796954","article-title":"Tat-tetanus toxin fragment C: a novel protein delivery vector and its use with photochemical internalization","volume":"21","author":"Gramlich","year":"2013","journal-title":"J. Drug. Target."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/rej.2009.0920","article-title":"New strategies for enzyme replacement therapy for lysosomal storage diseases","volume":"13","author":"Grubb","year":"2010","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0160","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1016\/S0021-9258(18)83727-9","article-title":"Genetically engineered polymers of human CuZn superoxide dismutase","volume":"264","author":"Hallewell","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1476-5381.2009.00057.x","article-title":"Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics","volume":"157","author":"Heitz","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0170","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10238-011-0152-7","article-title":"VP22 enhances the expression of glucocerebrosidase in human gaucher II fibroblast cells mediated by lentiviral vectors","volume":"12","author":"Jin","year":"2012","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0175","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jbiotec.2015.02.008","article-title":"Effect of linker flexibility and length on the functionality of a cytotoxic engineered antibody fragment","volume":"199","author":"Klement","year":"2015","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0180","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0185","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bbrc.2005.05.207","article-title":"Improved intracellular delivery of glucocerebrosidase mediated by the HIV-1 Tat protein transduction domain","volume":"337","author":"Lee","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0190","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/jmr.300030205","article-title":"Rabies virus binding to an acetylcholine receptor \u03b1-subunit peptide","volume":"3","author":"Lentz","year":"1990","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0195","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bbrc.2009.05.079","article-title":"Recombinant GDNF: tetanus toxin fragment C fusion protein produced from insect cells","volume":"385","author":"Li","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0200","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2009.02.051","article-title":"Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles","volume":"30","author":"Liu","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0205","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ana.20444","article-title":"Convention perfusion of glucocerebrosidase for neuronopathic Gaucher's disease","volume":"57","author":"Lonser","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0210","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1212\/01.wnl.0000247744.10990.e6","article-title":"Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease","volume":"68","author":"Lonser","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0215","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1126\/science.1246619","article-title":"Structure, function, and evolutionary relationships of Fc domains of human immunoglobulins A, G, M, and E","volume":"191","author":"Low","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0220","unstructured":"Mello, N., Gramlich, P.A., Remington, M.P., Fishman, P.S., 2015. Rabies glycoprotein derived peptide shows enhanced neuronal internalization of GFP compared to tetanus toxin fragment C, Tat, and Tet-1. Unpublished results, (in preparation)."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0225","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1073\/pnas.052023599","article-title":"Neuronal activity-dependent membrane traffic at the neuromuscular junction","volume":"99","author":"Miana-Mena","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0230","doi-asserted-by":"crossref","first-page":"18054","DOI":"10.1073\/pnas.1207889109","article-title":"Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease","volume":"109","author":"Panicker","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0235","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/stem.1732","article-title":"Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development","volume":"32","author":"Panicker","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0240","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/11318540-000000000-00000","article-title":"Recombinant glucocerebrosidase (imiglucerase) as a therapy for Gaucher disease","volume":"24","author":"Pastores","year":"2010","journal-title":"BioDrugs"},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0245","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s40265-014-0296-3","article-title":"Eliglustat: first global approval","volume":"74","author":"Poole","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0250","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1014915430398","article-title":"Uptake of mannose-terminal glucocerebrosidase in cultured human cholinergic and dopaminergic neuron cell lines","volume":"27","author":"Schueler","year":"2002","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0255","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction: delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0260","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1467-7652.2007.00263.x","article-title":"Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system","volume":"5","author":"Shaaltiel","year":"2007","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0265","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1073\/pnas.0702170104","article-title":"Targeted delivery of proteins across the blood\u2013brain barrier","volume":"104","author":"Spencer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0270","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1074\/jbc.M111.280016","article-title":"Ex vivo and in vivo effects of isofagomine on acid \u03b2-glucosidase variants and substrate levels in Gaucher disease","volume":"287","author":"Sun","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0275","article-title":"March 8,. Substrate compositional variation with tissue\/region and Gba1 mutations in mouse models-implications for Gaucher Disease","author":"Sun","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0280","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20130081","article-title":"Glycosylation and functionality of recombinant \u03b2-glucocerebrosidase from various production systems","author":"Tekoah","year":"2013","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0285","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/protein\/6.1.101","article-title":"Restructuring an interdomain linker in the dihydrolipoamide acetyltransferase component of the pyruvate dehydrogenase complex of Escherichia coli","volume":"6","author":"Turner","year":"1993","journal-title":"Protein Eng."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0290","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/357407a0","article-title":"Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene","volume":"357","author":"Tybulewicz","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0295","first-page":"491","article-title":"HIV Tat variants differentially influence the production of glucocerebrosidase in Sf9 cells","volume":"4","author":"Vaags","year":"2005","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0300","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/glycob\/cwm008","article-title":"Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease","volume":"17","author":"Van Patten","year":"2007","journal-title":"Glycobiology"},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0305","unstructured":"Westbroek, W., Nguyen, M., Burnett, R., Siebert, M., Aflaki, E., Behre, B., Costa, W., Rodriguez-Gil, J., Fujiwara, H., Sidhu, R., Tayebi, N., Renvoise, B., Cramer, C., Pavan, W., Ory, D., Sidransky, E., 2015. A novel neuronal cell model for Gaucher type II. Unpublished results, (in preparation)."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0310","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/90242","article-title":"The HIV Tat protein transduction domain improves the biodistribution of \u03b2-glucuronidase expressed from recombinant viral vectors","volume":"19","author":"Xia","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0315","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3109\/1061186X.2010.523788","article-title":"Targeted delivery of large fusion protein into hippocampal neurons by systemic administration","volume":"19","author":"Xiang","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001207","article-title":"SV2 mediates entry of tetanus neurotoxin into central neurons","author":"Yeh","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0325","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.biotechadv.2014.11.005","article-title":"Synthetic fusion protein design and applications","volume":"33","author":"Yu","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0330","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.pnsc.2008.12.007","article-title":"Design and optimization of a linker for fusion protein construction","volume":"19","author":"Zhang","year":"2009","journal-title":"Prog. Nat. Sci."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0335","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1471-4159.2007.05030.x","article-title":"Cellular uptake and lysosomal delivery of galactocerebrosidase tagged with the HIV Tat protein transduction domain","volume":"104","author":"Zhang","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jbiotec.2016.01.015_bib0340","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.addr.2004.10.010","article-title":"Cell-penetrating peptides: mechanism and kinetics of cargo delivery","volume":"57","author":"Zorko","year":"2005","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Journal of Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165616300153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165616300153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T22:04:11Z","timestamp":1654121051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168165616300153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":68,"alternative-id":["S0168165616300153"],"URL":"https:\/\/doi.org\/10.1016\/j.jbiotec.2016.01.015","relation":{},"ISSN":["0168-1656"],"issn-type":[{"value":"0168-1656","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A peptide-linked recombinant glucocerebrosidase for targeted neuronal delivery: Design, production, and assessment","name":"articletitle","label":"Article Title"},{"value":"Journal of Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbiotec.2016.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}